ZaBeCor Pharmaceuticals

ZaBeCor Pharmaceuticals, LLC is a clinical-stage biotechnology company focused on developing siRNA, antisense, and other molecular technologies for the treatment of asthma, allergies, and other inflammatory and infectious diseases. Its products include Excellair, an anti-inflammatory drug for treating asthma, allergies, ARDS, COPD, avian influenza, uveitis, cystitis, rheumatoid arthritis, and other autoimmune and inflammatory conditions.